Sanofi-Aventis (France) Eyes Japan Generic Drug Market; To Invest 5 Billion Yen in Japan's Nichi-iko Pharmaceutical

Reuters -- French drugmaker Sanofi-Aventis said there was strong interest in the assets likely to be sold from its animal health operations and confirmed it was in talks with a partner to enter the Japanese generic drug market.

Back to news